Best Practice & Research Clinical Haematology
Volume 19, Issue 2 , Pages 281-292, June 2006

Autologous immune strategies to reduce the risk of leukemic relapse: Consideration for IL-15

The Ohio State University Medical Center, The Ohio State University, 458 A Starling Loving Hall, 320 W 10th Avenue, Columbus, OH 43210-1214, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(05)00106-4

doi:10.1016/j.beha.2005.11.004

Best Practice & Research Clinical Haematology
Volume 19, Issue 2 , Pages 281-292, June 2006